Background Retinal vein occlusion (RVO) is the second most common retinal vascular
disorder that affected 16.4 million people worldwide in 2008. The last decade has seen new …

Type 2 diabetes (T2D) and obesity are known as important chronic diseases in the world. A
common mechanism of pathogenesis in both diseases is the dysregulation of the insulin …

Purpose Retinal vascular occlusion is a leading cause of profound irreversible visual loss,
but the understanding of the disease is insufficient. We systematically investigated the age …

Background: This subgroup analysis of the RE-ENACT study evaluates the effectiveness of
Razumab®(the world's first biosimilar of ranibizumab by Intas Pharmaceuticals Ltd.) in …

Purpose. To evaluate the neutrophil/lymphocyte ratio (NLR) and the platelet/lymphocyte
ratio (PLR) value in the development of branch retinal vein occlusion (BRVO) patients …

Background This study aims to explore the prevalence and causes of low vision and
blindness focused on retinal disease in a population above 60 years in Nepal. Methods Two …

Background The “greying of AIDS”–the aging of the population living with HIV who benefit
from antiretroviral treatment (ART) and the emergence of age-related non-communicable …

Retinal vein occlusion (RVO) is the second most common etiology for vision loss. There is
contrasting evidence on the association between diabetes mellitus (DM) and the risk of …

Introduction Retinal diseases are an emerging cause of visual impairment in the developing
world. The aim of this study was to explore the prevalence, pattern, and risk factors of retinal …

Purpose: The aim of this study was to examine the prevalence and incidence of retinal vein
occlusions (RVO) in Europe. Methods: A systematic review and meta-analysis of the …